Revolution Medicines starts a big study for a new lung cancer treatment.

Oct 20, 2026, 1:03 PM ETTrialRead the original at Benzinga

Good for RVMD

Revolution Medicines has begun a late-stage study after early patients showed tumor responses. The new study must still show whether zoldonrasib helps patients.

RVMD · Revolution Medicines Inc.

AI read · Good for RVMD

The AI's read

This gives Revolution Medicines a chance to test the treatment in a later-stage study. Earlier results showed tumor responses in a small group of patients. Those early findings are encouraging, but the new study has not yet shown whether the treatment works.

Get alerts for RVMD

Follow Revolution Medicines Inc. (RVMD) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for RVMD

Free on the App Store and Google Play, or on the web.